Omeprazol Auro (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Auro, is a proton pump inhibitor presented as a unknown strength/unknown form for oral use. It treats gastro‑reflux disease (GERD) and ulcers in adults and children where acid reduction is required.

GNH USA supplies Omeprazol Auro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Auro is a proton pump inhibitor that reduces gastric acid secretion in several acid‑related conditions. - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining. - Peptic ulcer disease: supports ulcer healing by maintaining a less acidic stomach environment. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with this rare endocrine disorder.

Adverse reactions to Omeprazole may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Headache: mild, transient headache reported by some patients. - Diarrhea: loose stools occurring during the initial weeks of treatment. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach region. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea indicating possible colitis. - Low magnesium levels: muscle cramps, irregular heartbeat, or seizures. - Fracture risk: increased incidence of hip, wrist or spine fractures with long‑term use. - Liver enzyme elevation: abnormal liver function tests. - Acute interstitial nephritis: kidney inflammation presenting with fever and flank pain.

Before starting Omeprazol Auro, consider the following safety measures: - Assess renal function: evaluate kidney health before chronic use. - Review hepatic status: check liver function in patients with liver disease. - Monitor long‑term use: limit duration when possible to reduce fracture risk. - Evaluate pregnancy status: discuss benefits versus risks with a prescriber. - Consider drug interactions: review concomitant medications for potential issues. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can affect the plasma levels of several co‑administered drugs. Proper monitoring helps maintain therapeutic effectiveness.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet activity, increasing cardiovascular event risk. - Atazanavir: markedly decreased antiviral absorption. - Dasatinib: increased exposure, raising toxicity potential.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, requiring more frequent coagulation monitoring. - Phenytoin: decreased phenytoin levels, possibly reducing seizure control. - Digoxin: slight rise in serum digoxin concentrations.